Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Prevention of stroke in atrial fibrillation Oral Anticoagulation EHRA Premium Access EHRA 2021

ESC 365 is supported by

ESC 365 is supported by